Nayoka Rimann

Safety and Immunogenicity of a Subvirion Monovalent Unadjuvanted Inactivated Influenza A(H3N2) Variant Vaccine in Healthy Persons ≥18 Years Old

M. Mulligan, W. Keitel, Shital M. Patel, 2015, The Journal of infectious diseases.

Risk Factors for Vitamin D Deficiency and Relationship with Cardiac Biomarkers, Inflammation and Immune Restoration in HIV-Infected Youth

M. Mulligan, A. Fitzpatrick, S. Judd, 2012, Antiviral therapy.

Point-of-Use Mixing of Influenza H5N1 Vaccine and MF59 Adjuvant for Pandemic Vaccination Preparedness: Antibody Responses and Safety. A Phase 1 Clinical Trial

D. Bernstein, M. Mulligan, N. Rouphael, 2014, Open forum infectious diseases.

Risk Factors for Vitamin D Deficiency and Relationship with Cardiac Biomarkers, Inflammation and Immune Restoration in HIV-Infected Youth

M. Mulligan, A. Fitzpatrick, S. Judd, 2012, Antiviral therapy.